MSU-TnT4 Insect Cell Line for Membrane Protein Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current baculovirus expression vector systems (BEVS) face limitations in expressing membrane proteins at high levels, with only a few commercially available insect cell lines, such as Sf21 and Hi-5, which are insufficient for comprehensive protein production, particularly for membrane proteins crucial in medical and agricultural applications.
Innovation Solution
Development of a new insect cell line, MSU-TnT4, derived from Trichoplusia ni embryos, which is capable of expressing human membrane proteins like neurotensin receptor 1, cannabinoid receptor 2, cytokine receptor 2B, natriuretic peptide receptor C, and transient receptor potential vanilloid 4 to high levels, utilizing recombinant baculoviruses and enhanced green fluorescent protein fusion proteins for evaluation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing insect cell lines (Sf21, Hi-5) are used for protein expression, then general protein production is achieved, but membrane protein expression levels remain insufficient
Solution Approach 1:
The patent changes the fundamental parameter of cell line origin by establishing a new cell line from Trichoplusia ni embryos rather than using existing lines. This parameter change results in a cell line with superior capability for membrane protein expression while maintaining versatility for other protein types
Solution Approach 2:
The patent segments the limited cell line options by creating a distinct new cell line (MSU-TnT4) with specialized capabilities for membrane proteins, while existing cell lines continue to serve for other protein types, thereby expanding the overall system versatility
2Adaptability or versatility
If a broader selection of cell lines is developed, then versatility of BEVS increases, but currently only a few cell lines are commercially available
Solution Approach 1:
The patent performs preliminary action by establishing and characterizing the MSU-TnT4 cell line in advance, with pre-validated expression capabilities for multiple membrane proteins. This preliminary development reduces future complexity by providing a ready-to-use cell line rather than requiring new development for each protein expression need
3Productivity
If membrane proteins are expressed in heterologous systems, then some expression success is achieved, but high-level expression for structural studies remains unattainable
Solution Approach 1:
The patent creates a copied and optimized insect cell system (MSU-TnT4) that replicates and enhances the natural environment for membrane protein expression. This copied system provides reliable high-level expression by combining insect cell biology with optimized culture conditions specifically tailored for membrane proteins
Data Source
AI summary
An isolated cell from the cell line identified as TnT4. This cell may be infected with a baculovirus expression vector which may carry a heterologous nucleotide that encodes a polypeptide, such as a membrane protein, e.g., human neurotensin receptor 1. Also included is a method for using this cell line to produce a polypeptide, such as a membrane protein; and a method for identifying a cell-of-interest which expresses a protein-of-interest.